Star Combo Pharma Ltd
ASX:S66
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.6), the stock would be worth AU$0.17 (26% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.8 | AU$0.23 |
0%
|
| 3-Year Average | 0.6 | AU$0.17 |
-26%
|
| 5-Year Average | 0.6 | AU$0.18 |
-20%
|
| Industry Average | 4.5 | AU$1.29 |
+472%
|
| Country Average | 2.7 | AU$0.76 |
+239%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Star Combo Pharma Ltd
ASX:S66
|
30.4m AUD | 0.8 | 5.6 | |
| FR |
|
L'Oreal SA
PAR:OR
|
199.5B EUR | 5.7 | 32.7 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
92.2B GBP | 6.9 | 11.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR | 11 | 37.1 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.2B GBP | 1.9 | 18.8 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28B USD | 6.8 | -155 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.8B EUR | 1.8 | 16.9 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 2.5 | 22.6 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 9.2 | 61.7 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -10 713 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
801.7B INR | 7.3 | 43.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
Star Combo Pharma Ltd
Glance View
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-16. The firm develops, manufactures, and distributes a range of branded vitamins, dietary supplements, and skincare products, serving both domestic and offshore markets. The firm operates through two segments: Star Combo business and Austoyou retail. Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skin care products. Austoyou retail business made up of the Australia-China e-commerce platform that offers products directly to Chinese health product consumers; and Koala Mall’s two retail stores in Sydney. Its products include Costar NMN, Costar osteo comples Gluco, Living Healthy and Little, Amax Top Marine Collagen E ,J&K Ultra nourishing colla and J&K Rose Oil Lanolin Cream. The company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance.
